Ellen Gielen
Europe Guide 2024
Band 3 : Life Sciences
Band 3
About
Provided by Ellen Gielen
Practice Areas
Ellen leads the Life Sciences & Healthcare sector group and is an expert in regulatory, compliance and complex contractual matters. She represents leading life science companies, like Amgen, Boston Scientific and Johnson & Johnson, on a wide range of pharmaceutical and medical device product issues, including manufacturing & distribution, pricing & reimbursement and advertising, both on domestic and EU level.
In this respect, Ellen is renowned for developing and securing innovative partnership models in the field of "patient support programs" and "hospital solutions". Ellen is also an experienced litigator related to life sciences matters.
Career
1997 - Lawyer at CMS
2015 - Partner at CMS
Professional Memberships
• Dutch Pharmaceutical Law Association
• Complaints Committee of a BOPZ Institution, an institution governed by the Psychiatric Hospitals Compulsory Admission Act
• Dutch Standardisation Institute (NEN) on MDR and IVDR topics (panel member)
Publications
• Expert Guides: A legal roadmap for Cannabis / Advertising of medicines and medical device / Digital health apps and telemedicines.
• On the pulse Podcast: A legal roadmap for Cannabis.
• Stay ahead Life Sciences and Healthcare – monthly update on legal developments.
Chambers Review
Europe
Ellen Gielen assists with regulatory medical devices mandates, as well as compliance and reimbursement issues in the pharmaceutical and agrosciences industries.
Strengths
Provided by Chambers
"Ellen Gielen is exceedingly knowledgeable and experienced with a hands-on approach."
"Ellen Gielen knows her business inside and out, making it easy to bounce ideas off her quickly and proceed with business in the right direction and legal framework."
"Ellen Gielen is exceedingly knowledgeable and experienced with a hands-on approach."
"Ellen Gielen knows her business inside and out, making it easy to bounce ideas off her quickly and proceed with business in the right direction and legal framework."